Horama's Series B - II Round

Horama raised a round of funding on September 19, 2018. Investors include V-Bio Ventures.

Horama, created in March 2014, is developing new gene therapies for the treatment of hereditary retinopathies pigmentosa, which are orphan ophthalmological diseases. Horama is a specialist in ophthalm…

Articles about Horama's Series B - II Round: